Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

2 closest matches · ranked by relevance

Phase 2 N=5 Nitisinone for Type 1B Oculocutaneous Albinism

Albinism · Vision Loss

Primary: Absolute Mean Change in Iris Pigmentation on an 8-point Iris Transillumination Scale at 12 Months as Compared to Baseline. Participants Left and Right Eyes Will be…

National Eye Institute (NEI) Results Nov 2017 0.0% serious AE View details

Phase 2 N=45 Trial of L-DOPA as a Treatment to Improve Vision in Albinism

Albinism

Primary: Improved Vision — 0.67; 0.55; 0.53 logMAR

University of Minnesota Results May 2018 0.0% serious AE View details